Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Berna Biotech's Spinout Kenta Raises CHF10M For Antibodies

May 10, 2006

By Cormac Sheridan

Borean Out-Licensing Apo A-I Atherosclerosis Drug To Roche

May 10, 2006

By Cormac Sheridan

Evotec Grosses EUR18.5M In Placement For CNS Drugs

May 3, 2006

By Cormac Sheridan

Pharmexa Moves GV1001 Into Pivotal Cancer Study

May 3, 2006

By Cormac Sheridan

Pharmexa Moves GV1001 Into Pivotal Cancer Study

May 3, 2006

By Cormac Sheridan

Evotec Grosses EUR18.5M In Placement For CNS Drugs

May 3, 2006

By Cormac Sheridan

Serono Hits Acquisition Trail In Search Of Adding Growth

April 26, 2006

By Cormac Sheridan

Serono Hits Acquisition Trail In Search Of Adding Growth

April 26, 2006

By Cormac Sheridan

Launch Of Europe's First Biogeneric Drug Imminent

April 19, 2006

By Cormac Sheridan

Rising TopoTarget Earns Priority Review From FDA

April 19, 2006

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...